Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/10/2019
SIETES contiene 92826 citas

 
 
 1 a 20 de 49 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. UN panel questions free market approach to R&D for medicines. DIA Daily 2016:1. [Ref.ID 100664]
2. Cita con resumen
Crow D. Poorer countries need rapid access to generic drugs, UN says. Financial Times 2016:1. [Ref.ID 100663]
3. Cita con resumen
Khare S, Nagle AS, Biggart A, Lai YH, Davis LC, Barnes W, Mathison CJN, Myburgh E, Gao M-Y, Gillespie JR, Liu X, Tan JL, Stinson M, Rivera IC, Ballard J, Yeh V, Groessl T, Federe G, Koh HXY, Venable JD, Bursulaya B, Shapiro M, Mishra PK, Spraggon G, Brock A, Mottram JC, Buckner FS, Rao SPS, Weng BG, Walker JR, Tuntland T, Molteni V, Glynne RJ, Supek F. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 2016:8 de agosto. [Ref.ID 100566]
4. Cita con resumen
Kesselheim AS, Laggs LR, Sarpatwari A. Experience with the priority review voucher program for drug development. JAMA 2015;314:27 de octubre. [Ref.ID 99526]
5.Tiene citas relacionadas
Maguire JH. Treatment of Chagas’ disease — Time is running out. N Engl J Med 2015;373:1369-70. [Ref.ID 99431]
6.Tiene citas relacionadas Cita con resumen
Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi Jr A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, for the BENEFIT Investigators. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373:1295-306. [Ref.ID 99430]
7. Cita con resumen
Kappagoda S, Ioannidis JPA. Neglected tropical diseases: survey and geometry of randomised evidence. BMJ 2012;345:17. [Ref.ID 94006]
8. Cita con resumen
Anónimo. Benznidazole: child adapted dosage form approved. WHO Drug Information 2012;26:21-2. [Ref.ID 92554]
9. Cita con resumen
Friedrich MJ. Promising leishmaniasis drug. JAMA 2012;307:1129. [Ref.ID 92537]
10.Tiene citas relacionadas Cita con resumen
Mitjà O, Hays R, Ipai A, Penias M, Paru R, Fagaho D, de Lazzari E, Bassat Q. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet 2012;379:342-7. [Ref.ID 92288]
11.Tiene citas relacionadas Cita con resumen
Mabey D. Oral azithromycin for treatment of yaws. Lancet 2012;379:295-7. [Ref.ID 92284]
12. Cita con resumen
Friedrich MJ. Chagas disease drug shortage. JAMA 2011;306:2082. [Ref.ID 91830]
13.Tiene citas relacionadas Cita con resumen
Hoffman SJ, Pogge T, Hollis A. New drug development. Lancet 2011;377:901-2. [Ref.ID 90325]
14.Tiene citas relacionadas Cita con resumen
Issa VS, Bocchi EA. Antitrypanosomal agents: treatment or threat?. Lancet 2010;376:768. [Ref.ID 89309]
15. Cita con resumen
Shetty P. Bernard Pécoul: championing the cause of neglected diseases. Lancet 2010;376:677. [Ref.ID 89245]
16.Tiene citas relacionadas Cita con resumen
Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SSS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, and the Pyronaridine-artesunate Study Team. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010;375:1457-67. [Ref.ID 88419]
17.Tiene citas relacionadas
Nosten FH. Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet 2010;375:1413-4. [Ref.ID 88412]
18.Tiene citas relacionadas Cita con resumen
Anónimo. Malaria 2010: more ambition and accountability please. Lancet 2010;375:1407. [Ref.ID 88409]
19.Tiene citas relacionadas Cita con resumen
Rassi Jr A, Rassi A, Marín-Neto JA. Chagas disease. Lancet 2010;375:1388-402. [Ref.ID 88363]
20. Cita con resumen
Richard Gold E, Kaplan W, Orbinski J, Harland-Logan S, S-Marandi N. Are patents impeding medical care and innovation?. PLOS Medicine 2010;7:208. [Ref.ID 87645]
Seleccionar todas
 
 1 a 20 de 49 siguiente >>